Data News > Investor Alert: Lawsuits Filed Against Applied Therapeutics, Inc. (APLT)
- Multiple law firms have filed class action lawsuits against Applied Therapeutics, Inc. for alleged securities fraud.
- Investors who suffered losses between January 3, 2024, and December 2, 2024, are encouraged to join the lawsuits.
- The lead plaintiff deadline for the class action lawsuits is February 18, 2025.
- Various law firms, including Levi & Korsinsky, are representing shareholders in these legal actions.
- Contact information for legal representation and submission forms can be found online.
Several law firms, including Levi & Korsinsky, Bronstein, Gewirtz & Grossman LLC, Pomerantz Law Firm, and The Schall Law Firm, have initiated class action lawsuits against Applied Therapeutics, Inc. (NASDAQ:APLT) for alleged securities violations during the period from January 3, 2024, to December 2, 2024. Investors who suffered losses during this timeframe are urged to participate in these legal actions.
The lawsuits aim to recover damages for all individuals and entities that purchased or acquired Applied Therapeutics securities within the specified Class Period. These law firms are inviting investors with substantial losses to lead the class action lawsuits and hold the Company and its officers accountable for the alleged violations of federal securities laws.
For investors interested in joining the class action lawsuits, the lead plaintiff deadline is set for February 18, 2025. To learn more about the potential recovery under federal securities laws and to participate in the legal proceedings, individuals can visit the websites provided by the law firms or reach out to the specified contacts for more information.
Investors with losses on their Applied Therapeutics, Inc. investments are advised to contact the law firms involved in these class action lawsuits promptly. By engaging in these legal actions, shareholders may have the opportunity to recover losses incurred during the Class Period and seek justice for any alleged securities fraud committed by the Company and its officers.
As the deadline to join the class action lawsuits approaches, investors are reminded to stay informed about the legal proceedings and take appropriate action to protect their rights and financial interests. By participating in these lawsuits, individuals may have the chance to secure a potential recovery and hold Applied Therapeutics, Inc. accountable for any wrongdoing during the specified timeframe.
For investors who wish to learn more or join the ongoing class action lawsuits against Applied Therapeutics, Inc., it is crucial to reach out to the law firms handling these cases before the lead plaintiff deadline of February 18, 2025. Stay informed and take the necessary steps to potentially recover losses and address any alleged securities fraud associated with your investment in the Company.
For more information:
Up/Down Rally Price Distribution Analyst Recommendations Earning Price Impact Analysis Seasonality
Investor Alert: Lawsuits Filed Against Applied Therapeutics, Inc. (APLT)
By KlickAnalytics Data Insights | December 31, 2024 08:01PM ET
Key Points
- Multiple law firms have filed class action lawsuits against Applied Therapeutics, Inc. for alleged securities fraud.
- Investors who suffered losses between January 3, 2024, and December 2, 2024, are encouraged to join the lawsuits.
- The lead plaintiff deadline for the class action lawsuits is February 18, 2025.
- Various law firms, including Levi & Korsinsky, are representing shareholders in these legal actions.
- Contact information for legal representation and submission forms can be found online.
Several law firms, including Levi & Korsinsky, Bronstein, Gewirtz & Grossman LLC, Pomerantz Law Firm, and The Schall Law Firm, have initiated class action lawsuits against Applied Therapeutics, Inc. (NASDAQ:APLT) for alleged securities violations during the period from January 3, 2024, to December 2, 2024. Investors who suffered losses during this timeframe are urged to participate in these legal actions.
The lawsuits aim to recover damages for all individuals and entities that purchased or acquired Applied Therapeutics securities within the specified Class Period. These law firms are inviting investors with substantial losses to lead the class action lawsuits and hold the Company and its officers accountable for the alleged violations of federal securities laws.
For investors interested in joining the class action lawsuits, the lead plaintiff deadline is set for February 18, 2025. To learn more about the potential recovery under federal securities laws and to participate in the legal proceedings, individuals can visit the websites provided by the law firms or reach out to the specified contacts for more information.
Investors with losses on their Applied Therapeutics, Inc. investments are advised to contact the law firms involved in these class action lawsuits promptly. By engaging in these legal actions, shareholders may have the opportunity to recover losses incurred during the Class Period and seek justice for any alleged securities fraud committed by the Company and its officers.
As the deadline to join the class action lawsuits approaches, investors are reminded to stay informed about the legal proceedings and take appropriate action to protect their rights and financial interests. By participating in these lawsuits, individuals may have the chance to secure a potential recovery and hold Applied Therapeutics, Inc. accountable for any wrongdoing during the specified timeframe.
For investors who wish to learn more or join the ongoing class action lawsuits against Applied Therapeutics, Inc., it is crucial to reach out to the law firms handling these cases before the lead plaintiff deadline of February 18, 2025. Stay informed and take the necessary steps to potentially recover losses and address any alleged securities fraud associated with your investment in the Company.
For more information:
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.